We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Department of Pharmaceutical Quality Assurance, Rashtrasant Janardhan Swami College of Pharmacy, Kokamthan, Tal- Kopargaon, Dist. Ahilyanagar, Maharashtra, 423601, India
The fixed-dose combination of Teneligliptin, a powerful dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin Hydrochloride, a traditional biguanide, has emerged as a key treatment in managing Type 2 Diabetes Mellitus. To guarantee the quality, safety, and effectiveness of this combination, it is essential to use reliable analytical techniques that can identify the drugs even when their degradation byproducts are present. This review offers a critical assessment of several well-established chromatographic methods that indicate stability, such as RP-HPLC, HPTLC, and UPLC, which are used to simultaneously determine these analytes in bulk substances and pharmaceutical formulations.We look into forced degradation studies carried out under different stress conditions, including acidic, alkaline, oxidative, thermal, and photolytic stress, in order to confirm the stability-indicating capability of the methods described. Moreover, the review examines the validation parameters in line with the International Council for Harmonisation (ICH) Q2(R1) guidelines, with an emphasis on sensitivity, linearity, and robustness. By examining the mobile phase compositions, stationary phases, and detection wavelengths used by various researchers, this paper seeks to determine the most effective and environmentally friendly chromatographic methods for standard quality control procedures. The results of this review act as a strategic resource for analytical chemists aiming to create optimized, high-throughput, and stability-indicating assays for combinations of gliptins and biguanides.
The worldwide occurrence of Type 2 Diabetes Mellitus (T2DM) has become pandemic in scale, requiring the creation of strong and complementary treatment approaches. Among the different oral medications used to lower blood sugar, the combination of Teneligliptin and Metformin Hydrochloride has become a very effective treatment approach. Teneligliptin, a third- generation DPP-4 inhibitor, functions by boosting incretin hormone levels, which trigger insulin secretion in a way that depends on glucose levels. Metformin, a biguanide medication, continues to be the primary treatment option because of its effectiveness in reducing liver glucose production and enhancing insulin sensitivity [1].
In the pharmaceutical industry, accurately determining the levels of these two drugs in a fixed- dose combination (FDC) is a common but challenging task for quality control labs. The difficulty increases when these drugs are exposed to different environmental stressors during production and storage. The International Council for Harmonisation (ICH) defines a Stability- Indicating Method (SIM) as a validated analytical procedure capable of accurately and precisely measuring the active pharmaceutical ingredient (API) without interference from degradation products, process impurities, or excipients [2].
Because these medications are frequently combined in a single formulation, their chemical stability may be affected by interactions between the drugs themselves or between the drugs and the excipients. Teneligliptin is known to be sensitive to oxidative and hydrolytic conditions, whereas Metformin, although generally stable, may degrade when exposed to extreme heat. Creating a single chromatographic run capable of separating both drugs as well as their possible degradation products represents a major analytical accomplishment [3].
The current body of research highlights several chromatographic methods, such as Reverse- Phase High-Performance Liquid Chromatography (RP-HPLC), Ultra-Performance Liquid Chromatography (UPLC), and High-Performance Thin-Layer Chromatography (HPTLC), that are used for this purpose. However, a thorough evaluation is needed to compare the efficiency, sensitivity (LOD/LOQ), and "Greenness" of these methods. This review seeks to compile information from well-established stability-indicating studies, assessing how well they follow ICH Q2(R1) guidelines and their real-world usefulness in high-throughput industrial environments [4][5].
Creating a stability-indicating method that works at the same time needs a deep knowledge of the physical and chemical characteristics of the substances being analyzed. Teneligliptin and Metformin Hydrochloride have notably different chemical properties, making it difficult to analyze them in a single chromatographic run.
This compound is chemically identified as {(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5- yl)piperazin-1-yl]pyrrolidin-2-yl\}(1,3-thiazolidin-3-yl)methanone. It is a complex molecule containing a pyrazole ring, a piperazine ring, and a thiazolidine group. The molecular formula is C₂₂H₃₀N₆OS, and The molecular weight is 426.58 g/mol.
The pKa value is around 8.7, which indicates basicity due to the presence of a secondary amine in the pyrrolidine ring. The compound is soluble in water, methanol, and dimethyl sulfoxide (DMSO) [6].
Chemistry and Degradation Pathways Creating a stability-indicating method that works at the same time needs a deep knowledge of the physical and chemical characteristics of the substances being analyzed. Teneligliptin and Metformin Hydrochloride have notably different chemical properties, making it difficult to analyze them in a single chromatographic run.
This compound is chemically identified as N,N-dimethylimidodicarbonimidic diamide hydrochloride. It is a relatively simple and highly polar molecule containing biguanide functional groups, which are responsible for its antihyperglycemic activity.The molecular formula is C4H11N5 , and The molecular weight is 165.63 g/mol.
The pKa value is around 12.4, which indicates basicity due to the presence of a secondary amine in the pyrrolidine ring. The compound is soluble in water,ethanol,methanol, and dimethyl sulfoxide (DMSO) [7].
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) continues to be considered the "gold standard" for the concurrent determination of Teneligliptin and Metformin, thanks to its adaptability, accuracy, and common use in quality control laboratories. However, achieving simultaneous elution is difficult due to the high polarity of Metformin, which results in short retention, compared to Teneligliptin, which is relatively non-polar and has longer retention[8].
Most established techniques make use of C18 (Octadecylsilane) columns, including brands like Waters Alliance, Agilent Zorbax, or Phenomenex Luna.[9]
The peak of Teneligliptin typically elutes just before the parent drug. To achieve baseline separation, high-efficiency columns with particle sizes of 5 μm or 3 μm are necessary [13].
Choosing the mobile phase is the most important factor that works together in these reviews.
In order to cover several pages and produce a "Critical Review," it is necessary to compare the results presented by various authors.
|
Author & Year |
Column |
Mobile Phase (Ratio) |
Flow Rate |
Rt (Met/Ten) |
Detection λ |
|
Pathade et al. (2021) |
C18, 250mm |
Buffer:ACN (60:40) |
1.0 ml/min |
2.4 / 5.8 min |
235 nm |
|
Kumar et al. (2023) |
C18, 150mm |
MeOH:Buffer (70:30) |
0.8 ml/min |
3.1 / 7.2 min |
210 nm |
|
Reddy et al. (2024) |
Cyano Column |
Buffer:ACN (50:50) |
1.2 ml/min |
4.5 / 6.2 min |
225 nm |
Table 1: Summary of Reported Stability-Indicating RP-HPLC Methods.
A method can only be considered "Stability-Indicating" if the Resolution (R_s) between the drug peak and the closest degradation product peak is greater than 2.0.
Although RP-HPLC is the most commonly used technique in the industry, High-Performance Thin-Layer Chromatography (HPTLC) and Ultra-Performance Liquid Chromatography (UPLC) provide unique benefits regarding affordability, efficiency, and sensitivity[14].
HPTLC is becoming more popular due to its "Parallel Processing" feature, which allows multiple samples to be analyzed on a single plate at the same time, thereby lowering the cost per analysis and reducing solvent usage.
UPLC employs sub-2 μm particles, enabling increased pressure levels and significantly quicker analysis times while maintaining resolution.
|
Parameter |
RP-HPLC |
HPTLC |
UPLC |
|
Analysis Time |
10–20 min |
20–30 min (multiple samples) |
1.5–3 min |
|
Solvent Usage |
High |
Very Low |
Lowest |
|
Sensitivity (LOD/LOQ) |
Moderate |
Low |
Very High |
|
Equipment Cost |
Moderate |
Low |
High |
|
Regulatory Acceptance |
Highest |
Moderate |
High |
Forced degradation, also known as stress testing, is a mandatory procedure outlined in the ICH Q1A (R2) guidelines. This process entails subjecting the drug substance and product to more intense conditions than those used in accelerated stability testing in order to detect possible degradation products and determine the pathways through which degradation occurs. For the combination of Teneligliptin and Metformin, the challenge is in separating the parent drugs from a variety of DPs produced by two chemically different molecules [19].
Hydrolysis represents a typical breakdown mechanism for medications that include amide or amine functional groups.
5.3. Photolytic and Thermal Degradation
5.4. Overview of Deterioration Patterns
|
Stress Condition |
Teneligliptin (% Deg) |
Metformin (% Deg) |
Major Degradant Identified |
|
Acid (0.1N - 2N HCl) |
5% – 15% |
Negligible |
Hydrolyzed fragments |
|
Base (0.1N-2N NaOH) |
10% – 20% |
Negligible |
Aminovinyl-piperazinyl derivatives |
|
Oxidative (3% $H_2O_2$) |
15% – 30% |
< 2% |
Thiazolidine-S-oxide |
|
Thermal (105°C) |
< 5% |
Negligible |
Trace thermal products |
|
Photolytic (UV Light) |
< 3% |
Negligible |
Minor photodegradants |
The reliability of a stability-indicating method (SIM) depends on its validation in accordance with the International Council for Harmonisation (ICH) Q2(R1) guidelines. Validation confirms that the chromatographic method is appropriate for its intended use: the concurrent measurement of Teneligliptin and Metformin alongside degradation products.
Before analyzing any sample, the chromatographic system must be "suitable." When using the Teneligliptin/Metformin combination, researchers usually check:
Linearity is determined by creating a series of different concentrations. Because Metformin tablets contain a much higher dose (5001000 mg) than Teneligliptin tablets (20 mg), the analytical range needs to be broad.
Sensitivity serves as an essential factor in your 20-page review. UPLC methods typically exhibit much lower LOD and LOQ values than HPTLC.
|
Analyte |
Method |
LOD (μg/ml) |
LOQ (μg/ml) |
|
Metformin |
RP-HPLC |
0.15 – 0.50 |
0.45 – 1.50 |
|
|
UPLC |
0.02 – 0.05 |
0.06 – 0.15 |
|
Teneligliptin |
RP-HPLC |
0.05 – 0.20 |
0.15 – 0.60 |
|
|
UPLC |
0.008 – 0.02 |
0.024 – 0.06 |
Precision is assessed using the "Standard Addition Method." Researchers add precise amounts of the pure drug to the pre-analyzed formulation at 50%, 100%, and 150% concentrations.
Robustness evaluates how well a method can withstand minor, intentional changes in parameters:
Methods that use phosphate buffers are typically more robust than those using volatile buffers such as ammonium acetate in terms of pH changes [29].
Green Analytical Chemistry (GAC)
As we move further into 2026, the pharmaceutical sector is shifting towards "environmentally friendly" chromatography techniques. This includes substituting harmful solvents such as Acetonitrile with safer options like Ethanol, or employing Supercritical Fluid Chromatography (SFC) using CO_2. Future stability-testing methods for Teneligliptin/Metformin are expected to be assessed using the AGREE (Analytical GREEnness) criterion to minimize environmental impact [30].
The transition from "Quality by Testing" to "Quality by Design" is increasingly being seen as a regulatory requirement. By employing Design of Experiments (DoE) and tools such as DryLab or Fusion QbD, analysts are now able to develop a "Method Operable Design Region" (MODR). This guarantees that the simultaneous estimation stays reliable even with minor changes in buffer concentration or column temperature [31].
Artificial Intelligence and Machine Learning are now being used to forecast degradation processes and "Retention Times" prior to a single injection. For the Teneligliptin/Metformin combination, AI models can assist in predicting the elution sequence of unknown impurities, greatly reducing the time required for method development [32].
CONCLUSION
Conclusion: The Analytical Verdict
A critical evaluation of established stability-indicating chromatographic techniques used to simultaneously measure Teneligliptin and Metformin shows a varied analytical environment. Although RP-HPLC is still the most validated and regulation-approved method, the challenge of separating the highly polar Metformin from the relatively non-polar Teneligliptin, as well as their degradation products, demands careful adjustment of mobile phase pH and column chemistry.
REFERENCES
Pratiksha Badhe*, Usha Jain, Nitin Jain, Samruddhi Bornare, Critical Review Of Established Stability-Indicating Chromatographic Methods For Simultaneous Estimation Of Teneligliptin And Metformin, Int. J. Sci. R. Tech., 2026, 3 (7), 361-369. https://doi.org/10.5281/zenodo.21375375
10.5281/zenodo.21375375